Colon cancer is a common malignant tumor of the digestive system. In the world, the incidence and mortality of colorectal cancer rank the third among malignant tumors. Although there have been great advances in the technical means of this treatment in recent years, the mortality rate continues to rise. Studies have shown that inflammasomes are an important type of polyprotein complex in the innate immune system, which play an important role in identifying and eliminating intestinal pathogens and maintaining intestinal homeostasis. Their abnormal functions are involved in inflammatory bowel disease. And its carcinogenesis. The inflammasome is the central link of the inflammatory response, which is of great significance in the study of many functions and related mechanisms in colon cancer.

Haonan Chen, Yuehang Zhang, Shupei Deng, Xu Deng. Mini review: the relationship between inflammasome and colon cancer. Frontiers in Medical Science Research (2021) Vol. 3 Issue 2: 21-23. https://doi.org/10.25236/FMSR.2021.030206.

[1] Li Kaiyue. Research on the anti-colon cancer mechanism of Fuzheng Xiaoliu Decoction based on systemic pharmacology [D]. Northwest Sci-Tech University of Agriculture and Forestry, 2020.

[2] Wu Xuesong. The role and mechanism of glycolysis in the progression of colorectal cancer induced by inflammasome activation [D]. Zhejiang University, 2019.

[3] Huang Fengze, Liang Wanwang, Sun Daxin. NLRP1 inflammasome and tumor research progress [J]. Chinese Journal of Cancer Prevention and Treatment, 2020, 12(05): 594-598.

[4] Chen Jintong, Wang Chengdang. The relationship between inflammasome and inflammatory bowel disease and its carcinogenesis [J]. Gastroenterology, 2013, 18(03): 175-178.

[5] Chen Jianglong, Chen Lin, Lu Zhibao. Research progress in the post-transcriptional and post-translational regulation mechanisms of NLRP3 inflammasome activation [J]. International Journal of Immunology, 2020, 43(06): 670-676.

[6] Moossavi M, Parsamanesh N, Bahrami A, et al. Role of the NLRP3 inflammasome in cancer [J]. Mol Cancer, 2018, 17(1): 1- 13

[7] Jin C, Flavell RA. Molecular mechanism of NLRP3 inflamasome activation [J]. J Clin Immunol, 2010, 30 (5): 628-631.

[8] Nan Song, Zhao-Shan Liu, Wen Xue, Zhao-Fang Bai, Qian-Yi Wang, Jiang Dai, Xin Liu, Yi-Jiao Huang, Hong Cai, Xiao-Yan Zhan, Qiu-Ying Han, Hongxia Wang, Yuan Chen, Hui-Yan Li, Ai-Ling Li, Xue-Min Zhang, Zhou Tao, Li Tao. Phosphorylation of NLRP3 is a key molecular event for inflammasome activation [J]. Science News, 2018 (04): 88.

[9] Ruan Ping. The role of inflammasome NLRP3 in tumors [J]. Medical Theory and Practice, 2021, 34(01): 23-25.

[10] KANTONO M, GUO B.Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development [J]. Front Immunol, 2017, 8: 1132